PPARG and hepatocellular carcinoma: Using several HCC cell lines, including HepaRG and HBG-BC2 cells that exhibit well-characterized differentiation and retrodifferentiation potential [7, 11, 15], we showed that hepatic CSCs derived from retrodifferentiation of differentiated tumor-derived hepatocytes express PPARG and adopt a specific metabolic profile associated with chemoresistance.